Glomerulonephritis Clinical Trials in Prague
3 recruitingPrague, Czechia
Showing 1–3 of 3 trials
Recruiting
Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
C3 GlomerulopathyImmune-complex-membranoproliferative Glomerulonephritis
Novartis Pharmaceuticals225 enrolled50 locationsNCT03955445
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion
Sanofi84 enrolled69 locationsNCT06500702
Recruiting
Phase 2
Rescue of Nephrons With ALE.F02 (RENAL-F02)
Glomerulonephritis Rapidly Progressive
Alentis Therapeutics AG80 enrolled49 locationsNCT06047171